227 related articles for article (PubMed ID: 2839079)
1. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
[TBL] [Abstract][Full Text] [Related]
2. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
3. Effector mechanisms of peptides of the VIP family.
Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
5. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
6. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
[TBL] [Abstract][Full Text] [Related]
7. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
8. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes.
Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J
Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286
[TBL] [Abstract][Full Text] [Related]
9. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
[TBL] [Abstract][Full Text] [Related]
10. Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.
Robberecht P; Waelbroeck M; Coy D; De Neef P; Camus JC; Christophe J
Peptides; 1986; 7 Suppl 1():53-9. PubMed ID: 3018703
[TBL] [Abstract][Full Text] [Related]
11. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
12. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
13. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
[TBL] [Abstract][Full Text] [Related]
14. Species differences in the molecular characteristics of vasoactive-intestinal-peptide receptors in the pancreas from rat and guinea-pig.
Svoboda M; Poloczek P; Winand J; Robberecht P; Christophe J
Eur J Biochem; 1988 May; 174(1):59-66. PubMed ID: 2836201
[TBL] [Abstract][Full Text] [Related]
15. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
16. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
17. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
18. PACAP and VIP receptors in rat liver membranes.
Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
20. Secretin receptors in human pancreatic membranes.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Scemama JL; Fourmy D; Pradayrol L; Vaysse N; Christophe J
Pancreas; 1988; 3(5):529-35. PubMed ID: 3186683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
